Tag: venous thromboembolism

cancer patient

DOACs show promise over heparin injections in meta-analysis comparing cancer-associated VTE...

A recent meta-analysis found that direct oral anticoagulants (DOACs) appear to be a “reasonable alternative” to low molecular weight heparin (LMWH) for the treatment...

COVID-19 associated VTE: International thrombosis community urge WHO to act

The International Society on Thrombosis and Haemostasis (ISTH), on behalf of the international thrombosis community, have called on the World Health Organisation (WHO) to...

Study reports low rates of bleeding and VTE after 12 months...

Daiichi Sankyo Europe GmbH has announced results from five analyses of 12-month data from ETNA-VTE (Edoxaban treatment in routine clinical practice in patients with...

AHA and ISTH release joint statement on future VTE research priorities

The International Society on Thrombosis and Haemostasis (ISTH) and the American Heart Association (AHA) have released a joint scientific statement identifying the top five priorities for...

American Heart Association issues call to action to prevent VTE in...

Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the USA and worldwide. A new policy statement by the American Heart...
geko OnPulse

Geko device represents an alternative to IPC devices during COVID-19

Sky Medical Technology highlights a publication on 5 May 2020 in the Journal of Thrombosis and Haemostasis showing the incidence of venous thromboembolism (VTE) in...
compression

Compression stockings might not be needed to prevent blood clots after...

Compression stockings might be unnecessary to prevent blood clots in most patients undergoing non-emergency (elective) surgery, finds a clinical trial published by The BMJ...
COVID-19

New study addresses thromboembolic complications in COVID-19 patients

There is an “urgent need” to improve specific venous thromboembolism (VTE) diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19...

AVF releases white paper on considerations in prophylaxis and treatment of...

The COVID-19 subcommittee of the American Venous Forum (AVF) has issued a white paper on considerations in prophylaxis and treatment of venous thromboembolism (VTE)...
VTE treatment guideline with Anna Falanga and Nigel S Key

Updated VTE treatment guideline for patients with cancer revealed by ASCO

An updated guideline on the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer has been unveiled by the American Society of...
reduced hospital time and costs Xarelto

Paediatric trial finds rivaroxaban similar to standard anticoagulation in treatment of...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new results from the Phase 3 EINSTEIN-Jr study, showing paediatric patients (aged birth to...

Increased risk of VTE found in critically ill H1N1 patients with...

A new study has found that intensive care unit patients with swine flu (H1N1) and acute respiratory distress syndrome (ARDS) were 33 times more...
how is lower levels of serum bilirubin and venous thromboembolism related

Study finds significant association between low bilirubin levels and venous thromboembolism

A recent paper published by Hakan Duman (Recep Tayyip Erdoğan University, Rize, Turkey) and colleagues in the Journal of Vascular Surgery: Venous and Lymphatic...

BTG acquires Novate Medical

BTG has announced it has acquired Novate Medical, a medical device company focused on the prevention of pulmonary embolism in patients at high risk...

Cancer-associated VTE trial sees “lower rate of recurrent VTE with edoxaban...

Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in...
Venous News for specialists

Inari Medical announces completion of enrolment in the FLARE study for...

Inari Medical has announced that it has completed enrolment of its investigational device exemption (IDE) study. The FlowTriever Pulmonary Embolectomy Clinical Study (FLARE) study...

More evidence that statins could prevent blood clots in the veins

Further evidence has been found by researchers at the UK’s University of Leicester and University of Bristol to suggest statins could "significantly reduce" the...

Canadian study finds rivaroxaban more effective at preventing recurrent blood clots...

A Canadian-led international research team has found that the blood thinner rivaroxaban is as safe as aspirin, and more effective at preventing recurrence of...
Venous News for specialists

Use of computerised systems may help identify patients at decreased risk...

The use of computerised clinical decision support systems among surgical patients are associated with a significant increase in the proportion of patients with adequately...
Venous News for specialists

First patient enrolled in Daiichi Sankyo European edoxaban registry

The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...